Orphan drug strategy at NanoViricides shows faster approval for new treatments

By Proactive Investors / February 20, 2026 / www.youtube.com / Article Link

NanoViricides CEO Dr Anil Diwan outlines the next steps for NV-387 as the company prepares to begin Phase 2 dosing for Mpox ...

Recent News

Agnico Eagle's production dip and higher costs offset by jump in gold

February 17, 2026 / www.canadianminingreport.com

Barrick, Agnico Eagle report extremely strong Q4/25 results

February 17, 2026 / www.canadianminingreport.com

Metals far outpacing tech over past year

February 09, 2026 / www.canadianminingreport.com

Gold stocks gain on metal recovery

February 09, 2026 / www.canadianminingreport.com

Immediate trigger for crash was new Fed Chairman pick

February 02, 2026 / www.canadianminingreport.com

See all >